What is NDC 72865-192?

72865-192 is the product NDC for Potassium Citrate, Potassium citrate 10 meq/1 tablet, extended release, listed with the FDA by XLCare Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

XLCare Pharmaceuticals, Inc., NDC labeler code 72865. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Potassium Citrate?

37 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Potassium Citrate NDC 72865-192 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72865-192Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72865-0192Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72865-192-01	7286501920172865019201	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-192-01)Marketed from Feb 25, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Potassium Citrate
Generic name (nonproprietary): potassium citrate
Active ingredients: Potassium citrate — 10 meq/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: XLCare Pharmaceuticals, Inc.NDC labeler code 72865
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214420
Marketing start: Feb 15, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Acidifying Activity (Mechanism)Calcium Chelating Activity (Mechanism)Decreased Coagulation Factor Activity (Physiologic effect)
Identifiers: Product ID 72865-192_7809b770-e255-4e34-b38f-90a0d51eeaeaSPL ID 7809b770-e255-4e34-b38f-90a0d51eeaeaSPL set ID 360a1012-4bdb-473a-8f1f-4550d3b51343RxCUI 199376, 199381, 898490UNII EE90ONI6FFUPC 0372865193013, 0372865191019, 0372865192016
Pharmacologic class: Anti-coagulant; Calculi Dissolution Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472865019201 followed by a unit qualifier and the quantity

Package 72865-0192-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 21, 2022.

Indications (excerpt from the label)

Potassium citrate extended-release tablets are a citrate salt of potassium indicated for the management of: Renal tubular acidosis (RTA) with calcium stones (1.1) Hypocitraturic calcium oxalate nephrolithiasis of any etiology (1.2) Uric acid lithiasis with or without calcium stones (1.3) 1.1 Renal Tubular Acidosis (RTA) with Calcium Stones Potassium citrate is indicated for the management of renal tubular acidosis [see Clinical Studies (14.1)]. 1.2 Hypocitraturic Calcium Oxalate Nephrolithiasis of any Etiology Potassium citrate is indicated for the management of Hypocitraturic calcium oxalate nephrolithiasis [see Clinical Studies (14.2)] . 1.3 Uric Acid Lithiasis with or without Calcium Ston…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72865-192

What is NDC 72865-192?: 72865-192 is the product NDC for Potassium Citrate, Potassium citrate 10 meq/1 tablet, extended release, listed with the FDA by XLCare Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Potassium Citrate.
What is the active ingredient?: Potassium citrate.
Who is the labeler?: XLCare Pharmaceuticals, Inc., NDC labeler code 72865. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Potassium Citrate?: 37 other product NDCs are listed under this name. See all Potassium Citrate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Potassium Citrate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Potassium Citrate	Potassium citrate 10 meq/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4477	70518-4477-00
Potassium Citrate	Potassium citrate 540 mg/1	Tablet, Extended releaseOral	Rising Pharma Holdings, Inc.	16571-864	16571-0864-01
Potassium Citrate	Potassium citrate 1080 mg/1	Tablet, Extended releaseOral	Rising Pharma Holdings, Inc.	16571-865	16571-0865-01
Potassium Citrate	Potassium citrate 10 meq/1	TabletOral	Biocomp Pharma, Inc.	44523-410	44523-0410-01
Potassium Citrate	Potassium citrate 10 meq/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-3160	70518-3160-00
Potassium Citrate	Potassium citrate 5 meq/1	Tablet, Extended releaseOral	XLCare Pharmaceuticals, Inc.	72865-191	72865-0191-01
Potassium Citrate	Potassium citrate 5 meq/1	Tablet, Extended releaseOral	Camber Pharmaceuticals, Inc	31722-129	31722-0129-01
Potassium Citrate	Potassium citrate 10 meq/1	Tablet, Extended releaseOral	Camber Pharmaceuticals, Inc	31722-130	31722-0130-01
Potassium Citrate	Potassium citrate 15 meq/1	Tablet, Extended releaseOral	Camber Pharmaceuticals, Inc	31722-132	31722-0132-01
Potassium Citrate	Potassium citrate 15 meq/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	71335-2897	71335-2897-01

All 38 Potassium Citrate NDCs

Other NDCs under ANDA 214420

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214420
Product	Strength	Form · route	Labeler	Product NDC
Potassium Citrate	Potassium citrate 5 meq/1	Tablet, Extended releaseOral	Camber Pharmaceuticals, Inc	31722-129
Potassium Citrate	Potassium citrate 10 meq/1	Tablet, Extended releaseOral	Camber Pharmaceuticals, Inc	31722-130
Potassium Citrate	Potassium citrate 15 meq/1	Tablet, Extended releaseOral	Camber Pharmaceuticals, Inc	31722-132
Potassium Citrate	Potassium citrate 10 meq/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4477
Potassium Citrate	Potassium citrate 15 meq/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	71335-2897
Potassium Citrate	Potassium citrate 10 meq/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	72162-2120
Potassium Citrate	Potassium citrate 15 meq/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	72162-2121
Potassium Citrate	Potassium citrate 5 meq/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	72162-2122
Potassium Citrate	Potassium citrate 5 meq/1	Tablet, Extended releaseOral	XLCare Pharmaceuticals, Inc.	72865-191
Potassium Citrate	Potassium citrate 15 meq/1	Tablet, Extended releaseOral	XLCare Pharmaceuticals, Inc.	72865-193